Council for the Advancement of Science Writing

CASW Periscope

Courtesy of Kristen van Schie. (Originally published in the Mail & Guardian.)   The following story diagram—or Storygram—annotates an award-winning story to shed light on what makes some of the best science writing so outstanding. The Storygram series is a joint project of The Open Notebook and the Council for the Advancement of Science... more
Like a St. Patrick’s Day hangover, news of federal researchers courting liquor company executives for funding leaves a bad taste in the mouth of many who care about the quality and independence of the National Institutes of Health. The New York Times reported yesterday that the lead researchers on a $100 million study of the effects of... more
An extremely brief New York Times “Well” post published last week — “A ‘Sweet Spot’ for Heart Health” — suggests that people must be within a very narrow weight range–a body-mass index (BMI) of 21 to 23–if they want to reduce their risk of heart disease as much as possible. The Times... more
Our health care system in the United States is notorious for providing a lot of unnecessary medical care — something we’ve written about extensively. Doctors may provide that unnecessary care because they perceive that patients are expecting or requesting it. If health care professionals don’t provide the aggressive care that patients... more
The National Association of Science Writers established the Excellence in Institutional Writing Award to recognize high-caliber, publicly accessible science writing produced on behalf of an institution or other non-media organization. Entries close April 20. Article type: Grants & awardsArticle topic: NASW news
The story of development of vaccines against rubella and other childhood diseases in the 1960s pits a daring young biologist against his world-famous boss, testing that used prisoners, intellectually disabled children, and other disenfranchised subjects, political roadblocks that nearly derailed the research, and other elements of high drama.... more
Older adults who reported excessive daytime sleepiness were also more likely to have increasing levels of a protein called beta-amyloid in their brains over time, according to a study in JAMA Neurology. Beta amyloid deposits are one of several pathologic signs of Alzheimer’s disease. It’s an intriguing finding, and one that adds to a... more
When the roughly 52,000-member American College of Cardiology (ACC) meets — as it did this past weekend in Orlando for its 67th Annual Scientific Session — it’s a big deal. Not only does it generate significant media buzz, but some of the studies presented can lead to major changes in how heart disease is diagnosed and treated.... more
A highly anticipated clinical trial result for an expensive cholesterol-lowering drug drew plenty of news coverage over the weekend, with some stories declaring the drug, Praluent, reduced the risk of death. The Associated Press wrote: It’s the first time a cholesterol-lowering drug has reduced deaths since statins such as Lipitor and Crestor came... more